Introduction

This chapter explores the potential of messenger RNA (mRNA) as a treatment for cancer and the challenges of delivering it to specific areas of the body. It introduces Strand Therapeutics' innovative approach to programming mRNA to activate only in certain cell types, and discusses the FDA-approved clinical trial to test this treatment in cancer patients with solid tumors.